Advertisement

Topics

Bristol-Myers Squibb to divest Irish manufacturing facility to SK Biotek

05:11 EDT 19 Jun 2017 | Pharmaceutical Business Review

Bristol-Myers Squibb has agreed to divest its small molecule active pharmaceutical ingredient manufacturing facility in Swords, Ireland, to South Korea based SK Biotek, a subsidiary of SK Holdings.

Original Article: Bristol-Myers Squibb to divest Irish manufacturing facility to SK Biotek

NEXT ARTICLE

More From BioPortfolio on "Bristol-Myers Squibb to divest Irish manufacturing facility to SK Biotek"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...